The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat
- 27 June 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 307 (2) , 171-181
- https://doi.org/10.1016/0014-2999(96)00251-8
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain InjuryJournal of Cardiovascular Pharmacology, 1995
- A Selective N-Type Ca2+-Channel Blocker Prevents CA1 Injury 24 h following Severe Forebrain Ischemia and Reduces Infarction following Focal IschemiaJournal of Cerebral Blood Flow & Metabolism, 1994
- Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?Stroke, 1994
- Endothelin Levels Increase in Rat Focal and Global IschemiaJournal of Cerebral Blood Flow & Metabolism, 1994
- Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistNature, 1993
- Effect of EndothelinA-Receptor Antagonist BQ-123 and Phosphoramidon on Cerebral VasospasmJournal of Cardiovascular Pharmacology, 1993
- Thrombin is a regulator of astrocytic endothelin-1Brain Research, 1993
- BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionLife Sciences, 1993
- Functional endothelin-1 receptors in rat astrocytoma C6European Journal of Pharmacology: Molecular Pharmacology, 1991
- A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytesBrain Research, 1991